Last reviewed · How we verify
NCT05913453
Technical Failure During Colorectal Endoscopic Full Thickness Resection (EFTR): The "Through Thick and Thin" Study
trial in Endoscopic Full Thickness Resection (EFTR) in 77 participants. Completed in 31 January 2023.
31 December 2022
Quick facts
| Lead sponsor | Azienda Unità Sanitaria Locale della Romagna |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 77 |
| Start date | 30 November 2022 |
| Primary completion | 31 December 2022 |
| Estimated completion | 31 January 2023 |
| Sites | 1 location across Italy |
Conditions studied
- Endoscopic Full Thickness Resection (EFTR) — all drugs for Endoscopic Full Thickness Resection (EFTR) →
- Residual /Recurrent Colorectal Lesion — all drugs for Residual /Recurrent Colorectal Lesion →
- Full-thickness Resection Device (FTRD) — all drugs for Full-thickness Resection Device (FTRD) →
- Colorectal Adenoma — all drugs for Colorectal Adenoma →
Sponsor
Azienda Unità Sanitaria Locale della Romagna
Who can join
Adults 18 to 90, any sex, with Endoscopic Full Thickness Resection (EFTR) or Residual /Recurrent Colorectal Lesion. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Among advanced resection techniques, endoscopic full thickness resection (EFTR) allows closure and full-thickness resection by the use of the non-exposed full thickness resection device (FTRD). The study is a retrospective analysis of technical failure occurring during colorectal full-thickness resection. Full thickness resection is a safe and effective procedure for "difficult" colorectal lesions. However, technical failure can occur and to date there is no evidence about type and clinical consequences in this setting.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT05913453
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other Azienda Unità Sanitaria Locale della Romagna trials
Trials by the same sponsor.
- NCT06115564 — Microbiological Assessment of Bile in Patients Undergone to Endoscopic Retrograde Cholangiography (ERCP): the "Microbile · unknown
- NCT05690412 — Efficacy and Safety of Endoscopic Papillectomy in the Treatment of Ampullary Neoplasms. · unknown
- NCT05395013 — Efficacy and Safety of Plastic, Covered and Uncovered Self-expandable Metal Stents in the Treatment of Malignant Biliary · completed
- NCT06965036 — Risk Factors and Outcomes of Ischemic Stroke Associated With Tandem or Isolated Cervical Artery Occlusion in Anterior an · active not recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05913453 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Azienda Unità Sanitaria Locale della Romagna
- Last refreshed: 22 June 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05913453.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing